BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24812525)

  • 1. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.
    Díaz-López A; Moreno-Bueno G; Cano A
    Cancer Manag Res; 2014; 6():205-16. PubMed ID: 24812525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer.
    Martínez-Campa C; Álvarez-García V; Alonso-González C; González A; Cos S
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-155 and cancer metastasis: Regulation of invasion, migration, and epithelial-to-mesenchymal transition.
    Moutabian H; Radi UK; Saleman AY; Adil M; Zabibah RS; Chaitanya MNL; Saadh MJ; Jawad MJ; Hazrati E; Bagheri H; Pal RS; Akhavan-Sigari R
    Pathol Res Pract; 2023 Oct; 250():154789. PubMed ID: 37741138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research models and mesenchymal/epithelial plasticity of osteosarcoma.
    Yu X; Yustein JT; Xu J
    Cell Biosci; 2021 May; 11(1):94. PubMed ID: 34022967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells.
    Tolue Ghasaban F; Ghanei M; Mahmoudian RA; Taghehchian N; Abbaszadegan MR; Moghbeli M
    Heliyon; 2024 May; 10(9):e30599. PubMed ID: 38726188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT.
    Jia W; Tripathi S; Chakraborty P; Chedere A; Rangarajan A; Levine H; Jolly MK
    Oncotarget; 2020 Jul; 11(27):2611-2624. PubMed ID: 32676163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRMT5 orchestrates EGFR and AKT networks to activate NFκB and promote EMT.
    Huang L; Ravi M; Zhang XO; Verdejo-Torres O; Shendy NAM; Nezhady MAM; Gopalan S; Wang G; Durbin AD; Fazzio TG; Wu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial Cooperativity in miR200-Zeb Feedback Network can Control Epithelial-Mesenchymal Transition.
    Rashid M; Devi BM; Banerjee M
    Bull Math Biol; 2024 Mar; 86(5):48. PubMed ID: 38555331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of epithelial-mesenchymal transition.
    Steinestel K; Eder S; Schrader AJ; Steinestel J
    Clin Transl Med; 2014; 3():17. PubMed ID: 25050175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment.
    Tang Y; Durand S; Dalle S; Caramel J
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32759677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data- and theory-driven approaches for understanding paths of epithelial-mesenchymal transition.
    Hong T; Xing J
    Genesis; 2024 Apr; 62(2):e23591. PubMed ID: 38553870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of alternative polyadenylation in epithelial-mesenchymal transition of non-small cell lung cancer.
    Wu S; Qin X; Huang L
    Hum Mol Genet; 2024 Apr; 33(8):677-686. PubMed ID: 38224682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMT transcription factors activated circuits: A novel tool to study EMT dynamics and its therapeutic implications.
    Chen T; Jia W; Zhang B; Xie H; Wu Q
    Synth Syst Biotechnol; 2024 Mar; 9(1):1-10. PubMed ID: 38173810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-Mesenchymal Transition: Role in Cancer Progression and the Perspectives of Antitumor Treatment.
    Gaponova AV; Rodin S; Mazina AA; Volchkov PV
    Acta Naturae; 2020; 12(3):4-23. PubMed ID: 33173593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMT-induced immune evasion: connecting the dots from mechanisms to therapy.
    Imodoye SO; Adedokun KA
    Clin Exp Med; 2023 Dec; 23(8):4265-4287. PubMed ID: 37966552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel clinical therapeutics targeting the epithelial to mesenchymal transition.
    Kothari AN; Mi Z; Zapf M; Kuo PC
    Clin Transl Med; 2014; 3():35. PubMed ID: 25343018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresolved Complexity in the Gene Regulatory Network Underlying EMT.
    Lavin DP; Tiwari VK
    Front Oncol; 2020; 10():554. PubMed ID: 32477926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMT and tumor metastasis.
    Heerboth S; Housman G; Leary M; Longacre M; Byler S; Lapinska K; Willbanks A; Sarkar S
    Clin Transl Med; 2015; 4():6. PubMed ID: 25852822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging paradigms in cancer cell plasticity.
    Huh HD; Park HW
    BMB Rep; 2024 Apr; ():. PubMed ID: 38627950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying the Epithelial-to-Mesenchymal Transition (EMT) from Bench to Bedside.
    Brown MS; Muller KE; Pattabiraman DR
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.